Deborah Kay Armstrong


1979 …2019
If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Dive into the research topics where Deborah Kay Armstrong is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 7 Similar Profiles
Ovarian Neoplasms Medicine & Life Sciences
Breast Neoplasms Medicine & Life Sciences
Drug Therapy Medicine & Life Sciences
Platinum Medicine & Life Sciences
Carboplatin Medicine & Life Sciences
Neoplasms Medicine & Life Sciences
Paclitaxel Medicine & Life Sciences
Carcinoma Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 1979 2019

Advancing drug development in gynecologic malignancies

Beaver, J. A., Coleman, R. L., Arend, R. C., Armstrong, D. K., Bala, S., Mills, G. B., Sood, A. K. & Herzog, T. J., Aug 15 2019, In : Clinical Cancer Research. 25, 16, p. 4874-4880 7 p.

Research output: Contribution to journalArticle

Pharmaceutical Preparations
Drug Approval

A phase I study of intravenous or intraperitoneal platinum based chemotherapy in combination with veliparib and bevacizumab in newly diagnosed ovarian, primary peritoneal and fallopian tube cancer

Moore, K. N., Miller, A., Bell-McGuinn, K. M., Schilder, R. J., Walker, J. L., O'Cearbhaill, R. E., Guntupalli, S. R., Armstrong, D. K., Hagemann, A. R., Gray, H. J., Duska, L. R., Mathews, C. A., Chen, A., O'Malley, D., Gordon, S., Fracasso, P. M. & Aghajanian, C., Jan 1 2019, (Accepted/In press) In : Gynecologic oncology.

Research output: Contribution to journalArticle

Fallopian Tube Neoplasms
Maximum Tolerated Dose
Combination Drug Therapy
Poly Adenosine Diphosphate Ribose

Differences in presentation and survival of Asians compared to Caucasians with ovarian cancer: An NRG Oncology/GOG Ancillary study of 7914 patients

Fuh, K. C., Java, J. J., Chan, J. K., Kapp, D. S., Monk, B. J., Burger, R. A., Young, R. C., Alberts, D. S., McGuire, W. P., Markman, M., Bell, J., Ozols, R. F., Armstrong, D. K., Aghajanian, C., Bookman, M. A. & Mannel, R. S., Jan 1 2019, In : Gynecologic oncology.

Research output: Contribution to journalArticle

Ovarian Neoplasms
Clinical Trials

Final report on serial phase II trials of all-intraperitoneal chemotherapy with or without bevacizumab for women with newly diagnosed, optimally cytoreduced carcinoma of Müllerian origin

Krasner, C. N., Castro, C., Penson, R. T., Roche, M., Matulonis, U. A., Morgan, M. A., Drescher, C., Armstrong, D. K., Wolfe, J. K., Lee, H., Supko, J. G., Seiden, M., Birrer, M. J. & Dizon, D. S., Jan 1 2019, In : Gynecologic oncology.

Research output: Contribution to journalArticle

Drug Therapy
Survival Analysis

Immune-related adverse events requiring hospitalization: Spectrum of toxicity, treatment, and outcomes

Balaji, A., Zhang, J., Wills, B., Marrone, K., Elmariah, H., Yarchoan, M., Zimmerman, J. W., Hajjir, K., Venkatraman, D., Armstrong, D. K., Laheru, D., Mehra, R., Ho, W. J., Reuss, J. E., Heng, J., Vellanki, P., Donehower, R. C., Holdhoff, M. & Naidoo, J., Jan 1 2019, In : Journal of oncology practice. 15, 9, p. E825-E834

Research output: Contribution to journalArticle

Referral and Consultation